Company Monitoring Page for Mylan

latest headlines for company on cafepharma

Teva aims for 25% of U.S. EpiPen market by 2020
Drug Delivery Business News
Tue, 02/19/19 - 10:22 am
Tags:
Teva Pharmaceutical, Mylan, EpiPen, generics
Mylan launches Advair generic at 70% discount in US
Pharmaforum
Wed, 02/13/19 - 10:13 am
Tags:
Mylan, GSK, Advair, generics
Mylan takes step toward knocking down key patent for Biogen's top-seller
Biopharma Dive
Thu, 02/7/19 - 03:26 pm
Tags:
Mylan, Biogen, Tecfidera, patents, inter partes review
Mylan’s Generic Advair Breathes New Life into Asthma Market
Xtalks
Tue, 02/5/19 - 10:03 am
Tags:
Mylan, GSK, Advair, generics, FDA, asthma, Wixela Inhub
Mylan finally crosses the finish line with long-awaited generic of GlaxoSmithKline's Advair
Fierce Pharma
Wed, 01/30/19 - 06:58 pm
Tags:
Mylan, GSK, FDA, Advair, generics, Wixela Inhub
UnitedHealthcare, fueled by federal probes, sues generics makers for price fixing
Fierce Pharma
Tue, 01/22/19 - 11:48 am
Tags:
UnitedHealthcare, generics, price fixing, drug pricing, Mylan, Teva Pharmaceuticals, Sandoz, Actavis, Par Pharmaceutical, Sun Pharma, Aurobindo, Taro Pharmaceuticals
Adamis stock surges on release of EpiPen alternative
Marketwatch
Thu, 01/17/19 - 09:34 am
Tags:
Adamis, Mylan, Sandoz, EpiPens, Symjepi
Ironwood, Allergan set to resolve LINZESS patent litigation with Mylan
Pharmaceutical Business Review
Thu, 01/3/19 - 09:40 am
Tags:
Ironwood Pharmaceuticals, Mylan, patents, Linzess
Sandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
Fierce Pharma
Thu, 12/6/18 - 01:04 pm
Tags:
Novartis, Sandoz, generics, Symjepi, EpiPens, Teva Pharmaceutical, Mylan
Teva launches EpiPen generic at same price as Mylan's version
Biopharma Dive
Wed, 11/28/18 - 11:52 am
Tags:
Teva Pharmaceutical, Mylan, EpiPens, generics
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
Tags:
cancer, breast cancer, lung cancer, drug approvals, AstraZeneca, Takeda, Ariad Pharmaceuticals, Merck, Pfizer, Novartis, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Puma Biotechnology, Mylan, Genentech
Mylan, Theravance win FDA approval for COPD drug
Biopharma Dive
Mon, 11/12/18 - 11:37 pm
Tags:
Theravance, Mylan, Yupelri, COPD, FDA
Mylan N.V. Improves in the Third Quarter Thanks to International Sales
Motley Fool
Tue, 11/6/18 - 11:33 am
Tags:
Mylan, earnings
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Mon, 11/5/18 - 09:56 am
Tags:
Coherus, Neulasta, Mylan, biosimilars, Amgen
Early November Brings More Quarterly Reports
BioSpace
Sun, 11/4/18 - 02:38 pm
Tags:
earnings, Akcea, Mylan, Eli Lilly, Regeneron
Momenta starts countdown to biosimilars exit
EP Vantage
Mon, 10/1/18 - 02:55 pm
Tags:
Momenta Pharmaceuticals, Mylan, biosimilars
5th Humira biosimilar approved in EU as market entry nears
Biopharma Dive
Fri, 09/21/18 - 12:06 am
Tags:
Europe, biosimilars, AbbVie, Humira, Mylan, Hulio
FDA extends EpiPen expiration date to ease shortages
Biopharma Dive
Wed, 08/22/18 - 11:47 am
Tags:
Mylan, drug shortages, FDA, EpiPens
Mylan's EpiPen supply woes drag on
Biopharma Dive
Fri, 08/17/18 - 09:36 am
Tags:
Mylan, Pfizer, EpiPens, drug shortages
FDA Approves New Generic Version Of The EpiPen For Allergic Reactions
NPR
Thu, 08/16/18 - 06:45 pm
Tags:
EpiPens, generics, Teva Pharmaceutical, Mylan, allergic reaction

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.